These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7770566)

  • 21. Is DSM-IV bereavement exclusion for major depression relevant to treatment response? A case-control, prospective study.
    Corruble E; Falissard B; Gorwood P
    J Clin Psychiatry; 2011 Jul; 72(7):898-902. PubMed ID: 21208577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition and management of depression in a substance use disorder treatment population.
    Curran GM; Booth BM; Kirchner JE; Deneke DE
    Am J Drug Alcohol Abuse; 2007; 33(4):563-9. PubMed ID: 17668342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model for handling missing items on two depression rating scales.
    Gale T; Hawley C
    Int Clin Psychopharmacol; 2001 Jul; 16(4):205-14. PubMed ID: 11459334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening for depression in patients with medical hospitalization. Comparison of two self-evaluation scales and clinical assessment with a structured questionnaire].
    Cathébras P; Mosnier C; Lévy M; Bouchou K; Rousset H
    Encephale; 1994; 20(3):311-7. PubMed ID: 8088234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability and validity of two self-rating scales in the assessment of childhood depression.
    Fundudis T; Berney TP; Kolvin I; Famuyiwa OO; Barrett L; Bhate S; Tyrer SP
    Br J Psychiatry Suppl; 1991 Jul; (11):36-40. PubMed ID: 1840756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sertraline for the treatment of depression in Parkinson's disease.
    Meara J; Hobson P
    Mov Disord; 1998 May; 13(3):622. PubMed ID: 9613775
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of depressed dementia or demented depression].
    Azorin JM
    Encephale; 1994 Jun; 20 Spec No 2():281-4. PubMed ID: 8088247
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation methods of the efficacy of an antidepressive drug].
    Tignol J
    Encephale; 2000 Nov; 26 Spec No 5():67-70. PubMed ID: 11217529
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment utility of psychological assessment.
    Nelson-Gray RO
    Psychol Assess; 2003 Dec; 15(4):521-31. PubMed ID: 14692847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reliability and validity of the Coolidge Axis II Inventory: a new inventory for the assessment of personality disorders.
    Coolidge FL; Merwin MM
    J Pers Assess; 1992 Oct; 59(2):223-38. PubMed ID: 1432558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Depression and response: impact of personality and cognition].
    David I; Brunnauer A; Laux G; Zwick S
    Psychiatr Prax; 2009 Apr; 36(3):132-6. PubMed ID: 19173172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.
    Pitts AF; Samuelson SD; Meller WH; Bissette G; Nemeroff CB; Kathol RG
    Biol Psychiatry; 1995 Sep; 38(5):330-5. PubMed ID: 7495928
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
    Pasquini M; Biondi M; Costantini A; Cairoli F; Ferrarese G; Picardi A; Sternberg C
    Depress Anxiety; 2006; 23(7):441-8. PubMed ID: 16841345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DEWIPA--a standardized questionnaire for assessing knowledge about symptoms, etiology and psychopharmacologic treatment in patients with depressive episodes].
    Müller J; Luderer HJ
    Psychiatr Prax; 1999 Jul; 26(4):167-70. PubMed ID: 10457967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using self report measures to corroborate theories of depression: the specificity problem.
    McGrath RE; Ratliff KG
    J Pers Assess; 1993 Aug; 61(1):156-68. PubMed ID: 8377100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-remission of depression in the general population as assessed by the HAMD-7 scale.
    Bulloch AG; Patten SB
    Depress Anxiety; 2008; 25(5):393-7. PubMed ID: 17948276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation between informant-rated personality and clinician-rated depression in patients with memory disorders.
    Clark LM; Bosworth HB; Welsh-Bohmer KA; Dawson DV; Siegler IC
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jan; 13(1):39-47. PubMed ID: 10645735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of comorbid personality disorder and neuroticism on treatment outcome in first episode depression.
    Bock C; Bukh JD; Vinberg M; Gether U; Kessing LV
    Psychopathology; 2010; 43(3):197-204. PubMed ID: 20375542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A definite and a semidefinite questionnaire version of the Hamilton/melancholia (HDS/MES) scale.
    Bent-Hansen J; Lauritzen L; Clemmesen L; Lunde M; Kørner A
    J Affect Disord; 1995 Mar; 33(3):143-50. PubMed ID: 7790665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.